GLOBUS MEDICAL, INC. Litigation Settlement, Expense
GLOBUS MEDICAL, INC. (GMED) reported Litigation Settlement, Expense of $314.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2025-02-20
- GLOBUS MEDICAL, INC. litigation settlement, expense for the quarter ending 2024-12-31 was -$314.00K, a 225.60% decline year-over-year.
- GLOBUS MEDICAL, INC. litigation settlement, expense for the quarter ending 2024-09-30 was -$676.00K, a 123.12% decline year-over-year.
- GLOBUS MEDICAL, INC. litigation settlement, expense for the quarter ending 2024-06-30 was $1.33M.
- GLOBUS MEDICAL, INC. litigation settlement, expense for the quarter ending 2024-03-31 was -$31.00K.
- GLOBUS MEDICAL, INC. litigation settlement, expense for fiscal 2024 was $314.00K, a 27.65% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. litigation settlement, expense for fiscal 2023 was $434.00K, a 81.46% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. litigation settlement, expense for fiscal 2022 was $2.34M, a 60.46% decline from fiscal 2021.
- GLOBUS MEDICAL, INC. litigation settlement, expense for fiscal 2021 was $5.92M, a 65688.89% increase from fiscal 2020.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$990.00K derived: sum of 2 quarters · filed 2025-02-20 | $345.00K derived: sum of 3 quarters · filed 2025-02-20 | $314.00K 10-K · filed 2025-02-20 |
| 2024-09-30 | -$676.00K 10-Q · filed 2024-11-05 | $659.00K derived: sum of 2 quarters · filed 2024-11-05 | $628.00K 10-Q · filed 2024-11-05 | $878.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2024-06-30 | $1.33M 10-Q · filed 2024-08-06 | $1.30M 10-Q · filed 2024-08-06 | $1.55M derived: sum of 3 quarters · filed 2025-02-20 | $4.48M derived: sum of 4 quarters · filed 2025-02-20 |
| 2024-03-31 | -$31.00K 10-Q · filed 2024-05-07 | $219.00K derived: sum of 2 quarters · filed 2025-02-20 | $3.14M derived: sum of 3 quarters · filed 2025-02-20 | $403.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $3.17M derived: sum of 2 quarters · filed 2025-02-20 | $434.00K derived: sum of 3 quarters · filed 2025-02-20 | $434.00K 10-K · filed 2025-02-20 |
| 2023-09-30 | $2.92M 10-Q · filed 2024-11-05 | $184.00K derived: sum of 2 quarters · filed 2024-11-05 | $184.00K 10-Q · filed 2024-11-05 | |
| 2023-06-30 | -$2.74M 10-Q · filed 2024-08-06 | -$2.74M 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $2.34M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $2.34M 10-Q · filed 2023-11-07 | $7.75M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.34M 10-Q · filed 2023-08-03 | $7.75M derived: sum of 3 quarters · filed 2024-02-21 | $8.36M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $2.34M 10-Q · filed 2023-05-04 | $7.75M derived: sum of 2 quarters · filed 2024-02-21 | $8.36M derived: sum of 3 quarters · filed 2024-02-21 | $8.36M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $6.01M derived: sum of 2 quarters · filed 2024-02-21 | $6.01M derived: sum of 3 quarters · filed 2024-02-21 | $5.92M 10-K · filed 2024-02-21 |
| 2021-09-30 | $605.00K 10-Q · filed 2022-11-08 | $605.00K derived: sum of 2 quarters · filed 2022-11-08 | $511.00K 10-Q · filed 2022-11-08 | $323.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$94.00K 10-Q · filed 2022-08-04 | -$282.00K derived: sum of 3 quarters · filed 2023-02-21 | -$282.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$94.00K 10-Q · filed 2022-05-10 | -$282.00K derived: sum of 2 quarters · filed 2023-02-21 | -$282.00K derived: sum of 3 quarters · filed 2023-02-21 | -$85.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$188.00K derived: sum of 2 quarters · filed 2023-02-21 | $9.00K derived: sum of 3 quarters · filed 2023-02-21 | $9.00K 10-K · filed 2023-02-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $197.00K derived: sum of 2 quarters · filed 2021-11-04 | $197.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $197.00K 10-Q · filed 2021-08-04 | $197.00K 10-Q · filed 2021-08-04 | ||
| 2019-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $2.19M derived: sum of 2 quarters · filed 2022-02-17 | $2.19M 10-K · filed 2022-02-17 | |
| 2019-09-30 | $1.63M 10-Q · filed 2020-10-28 | $1.63M 10-Q · filed 2020-10-28 | ||
| 2018-12-31 | $5.88M 10-K · filed 2021-02-17 | |||
| 2017-12-31 | $2.67M 10-K/A · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |